Marc Mansour

Employment

• University College London Professor

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (68)

• Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia
  Science Translational Medicine 2025 DOI: 10.1126/scitranslmed.adr1476
  +Save
• Elevated mitochondrial membrane potential is a therapeutic vulnerability in Dnmt3a-mutant clonal hematopoiesis.
  Nature communications 2025 DOI: 10.1038/s41467-025-57238-2
  +Save
• A modular protein language modelling approach to immunogenicity prediction.
  PLoS computational biology 2024 DOI: 10.1371/journal.pcbi.1012511
  +Save
• Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemia.
  Blood 2024 DOI: 10.1182/blood.2024024300
  +Save
• T-ALL and T-LBL: a notch apart.
  Blood 2024 DOI: 10.1182/blood.2024026122
  +Save
• Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphoma.
  Haematologica 2024 DOI: 10.3324/haematol.2023.283981
  +Save
• ToTAL1y degraded - rapid dTAG proteolysis of TAL1 in T-cell acute lymphoblastic leukemia.
  Haematologica 2024 DOI: 10.3324/haematol.2023.284447
  +Save
• Noncoding mutations drive persistence of a founder preleukemic clone which initiates late relapse in T-ALL.
  Blood 2024 DOI: 10.1182/blood.2023021906
  +Save
• Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma.
  Cancers 2023 DOI: 10.3390/cancers15030647
  +Save
• The Clinicogenomic Landscape of Induction Failure in Childhood and Young Adult T-Cell Acute Lymphoblastic Leukemia.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 DOI: 10.1200/jco.22.02734
  +Save